S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Harrow Health (HROW) News Today

$10.85
-0.97 (-8.21%)
(As of 04/18/2024 ET)
SourceHeadline
MarketBeat logoHarrow Health, Inc. (NASDAQ:HROW) Sees Significant Increase in Short Interest
americanbankingnews.com - April 15 at 1:40 AM
marketbeat.com logoVanguard Group Inc. Has $25.29 Million Stock Holdings in Harrow Health, Inc. (NASDAQ:HROW)
marketbeat.com - April 13 at 4:31 AM
MarketBeat logoHarrow Health (NASDAQ:HROW) Coverage Initiated at Craig Hallum
americanbankingnews.com - April 13 at 3:40 AM
marketbeat.com logoHarrow Health (NASDAQ:HROW) Now Covered by Craig Hallum
marketbeat.com - April 11 at 8:12 AM
bizjournals.com logoMelt Pharmaceuticals raises $24 million for drug development
bizjournals.com - April 3 at 11:23 PM
finance.yahoo.com logoMelt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
finance.yahoo.com - April 2 at 9:50 AM
insidertrades.com logoOpaleye Management Inc. Acquires 50,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stock
insidertrades.com - March 29 at 8:23 AM
marketbeat.com logoHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Purchases $641,000.00 in Stock
marketbeat.com - March 28 at 7:28 PM
insidertrades.com logoMark L. Baum Acquires 9,000 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stock
insidertrades.com - March 26 at 4:44 AM
marketbeat.com logoInsider Buying: Harrow Health, Inc. (NASDAQ:HROW) CEO Acquires 9,000 Shares of Stock
marketbeat.com - March 25 at 11:31 AM
marketbeat.com logoB. Riley Cuts Harrow Health (NASDAQ:HROW) Price Target to $26.00
marketbeat.com - March 25 at 8:09 AM
insidertrades.com logoOpaleye Management Inc. Acquires 50,600 Shares of Harrow Health, Inc. (NASDAQ:HROW) Stock
insidertrades.com - March 23 at 8:49 AM
marketbeat.com logoHarrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 50,600 Shares
marketbeat.com - March 22 at 2:11 PM
finance.yahoo.com logoHarrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 21 at 5:33 PM
investorplace.com logoWhy Is Harrow (HROW) Stock Up 5% Today?
investorplace.com - March 20 at 8:34 AM
msn.com logoHarrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5M
msn.com - March 20 at 4:57 AM
investorplace.com logoHROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023
investorplace.com - March 19 at 11:07 PM
finance.yahoo.com logoHarrow Inc (HROW) Reports Substantial Revenue Growth Amidst Net Loss Expansion in 2023
finance.yahoo.com - March 19 at 7:18 PM
businesswire.com logoHarrow Announces Fourth Quarter and Year-End 2023 Financial Results
businesswire.com - March 19 at 5:45 PM
marketbeat.com logoShort Interest in Harrow Health, Inc. (NASDAQ:HROW) Expands By 9.1%
marketbeat.com - March 18 at 11:13 PM
benzinga.com logoEarnings Preview: Harrow Health
benzinga.com - March 18 at 1:07 PM
finance.yahoo.com logoHarrow (HROW) Fell on Lowering the Guidance
finance.yahoo.com - March 13 at 8:22 AM
marketbeat.com logoKennedy Capital Management LLC Acquires Shares of 121,808 Harrow Health, Inc. (NASDAQ:HROW)
marketbeat.com - March 10 at 6:54 AM
finance.yahoo.com logoHarrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
finance.yahoo.com - March 5 at 8:31 AM
marketbeat.com logoStifel Financial Corp Buys New Position in Harrow Health, Inc. (NASDAQ:HROW)
marketbeat.com - March 4 at 5:44 AM
marketbeat.com logoHarrow Health, Inc. (NASDAQ:HROW) Shares Acquired by Braidwell LP
marketbeat.com - March 1 at 10:18 AM
finance.yahoo.com logoHere’s How Harrow (HROW) Weighed on SRK Capital’s Performance
finance.yahoo.com - February 29 at 2:13 AM
businesswire.com logoHarrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
businesswire.com - February 15 at 4:01 PM
marketbeat.com logoJump Financial LLC Invests $1.04 Million in Harrow Health, Inc. (NASDAQ:HROW)
marketbeat.com - February 6 at 5:20 AM
marketbeat.com logoRice Hall James & Associates LLC Purchases Shares of 250,380 Harrow Health, Inc. (NASDAQ:HROW)
marketbeat.com - January 21 at 8:48 AM
msn.com logoHarrow says dry eye drug Vevye now available in US
msn.com - January 11 at 1:35 PM
finance.yahoo.com logoHarrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
finance.yahoo.com - January 11 at 8:34 AM
bizjournals.com logoHarrow Inc. partners with technology companies for dry eye prescription Vevye
bizjournals.com - January 3 at 4:40 PM
marketbeat.com logoShort Interest in Harrow Health, Inc. (NASDAQ:HROW) Drops By 20.0%
marketbeat.com - December 15 at 9:40 AM
markets.businessinsider.com logoHarrow Health’s Strong Sales Growth and Strategic Acquisitions Fuel Buy Rating
markets.businessinsider.com - December 9 at 7:47 AM
finance.yahoo.com logoHarrow Completes Transfer of the TRIESENCE® New Drug Application
finance.yahoo.com - November 29 at 8:24 AM
seekingalpha.com logoHROWM Harrow Health, Inc. NT CAL 27
seekingalpha.com - November 24 at 10:51 PM
finance.yahoo.com logoHarrow to Present at Two Investor Conferences in November
finance.yahoo.com - November 20 at 8:01 AM
benzinga.com logoHarrow Recent Insider Activity
benzinga.com - November 17 at 10:51 AM
msn.com logoHarrow Health (NASDAQ:HROW) Plummets on Dismal Q3 Print
msn.com - November 14 at 11:26 PM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Harrow Health (HROW), Synlogic (SYBX)
markets.businessinsider.com - November 14 at 6:26 PM
markets.businessinsider.com logoWhy Is Eyecare-Focused Harrow Health Stock Trading Lower Today?
markets.businessinsider.com - November 14 at 2:31 PM
finance.yahoo.com logoHarrow Health, Inc. (NASDAQ:HROW) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 14 at 1:25 PM
finance.yahoo.com logoHarrow Announces Third Quarter 2023 Financial Results
finance.yahoo.com - November 13 at 4:18 PM
morningstar.com logoHarrow Inc HROW
morningstar.com - November 5 at 2:55 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Guardant Health (GH), TELA Bio (TELA) and Harrow Health (HROW)
markets.businessinsider.com - October 24 at 9:13 AM
finance.yahoo.com logoHarrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
finance.yahoo.com - October 24 at 9:13 AM
seekingalpha.com logoImplications Of Harrow's Short-Term Guidance
seekingalpha.com - October 18 at 9:34 AM
finance.yahoo.com logoHarrow Health, Inc. Changes Corporate Name to Harrow, Inc.
finance.yahoo.com - September 29 at 9:14 AM
seekingalpha.com logoHarrow Health's 5-Year Guidance
seekingalpha.com - September 27 at 4:14 PM
Get Harrow Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter.

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

HROW Media Mentions By Week

HROW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HROW
News Sentiment

0.87

0.49

Average
Medical
News Sentiment

HROW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HROW Articles
This Week

3

2

HROW Articles
Average Week

Get Harrow Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:HROW) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners